Chun-Jen Liu
Hepatology — National Taiwan University Hospital, Taiwan
Chun-Jen Liu
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 410
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Sex Difference in the Impact of Steatotic Liver Disease on Incident Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. liver diseases, diabetes mellitus, tenofovir, carcinoma, hepatocellular, cohort studies, hepatitis, chronic, liver, aged, sex characteristics, sex, hepatitis b, hepatitis b, chronic, hepatitis, sex differences | Cancers (Basel) | 2026 | 0 |
| Metabolic Optimization and Risk of Metachronous Advanced Colorectal Neoplasia in Patients With MASLD. neoplasms, cohort studies, clinical medicine, adenoma | JAMA Netw Open | 2026 | 1 |
| Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up Study. tenofovir, pregnancy, mothers, follow-up studies, infectious disease transmission, vertical, viral load, hepatitis b e antigens, therapeutics, peripartum period, postpartum period, antiviral agents, child | JHEP Rep | 2026 | 0 |
| Chronic Viral Hepatitis with Concurrent MASLD: Dual Etiology Challenges. liver diseases, hepatitis, chronic, viruses, hepatitis | Clin Mol Hepatol | 2026 | 0 |
| Response to letter to the editor. | J Formos Med Assoc | 2026 | 0 |
Clinical Studies 30
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Development of Microbial Therapeutics for Metabolic associated Fatty Liver Disease From Mechanistic Investigations to Clinical Trials NCT06873165 — liver diseases, liver, capsules, probiotics, therapeutics, fatty liver, akkermansia | N/A | Recruiting | 2025 |
| Chronic Hepatitis B Patients With Concurrent MAFLD Cohort Study and Exercise Intervention NCT05956379 — liver diseases, exercise, physical therapists, swimming, exercise test, non-alcoholic fatty liver disease, cohort studies, prescriptions, hepatitis, chronic, liver, alcoholics, hepatitis a, walking, jogging, hepatitis b, fatty liver, gastrointestinal microbiome, metabolic syndrome, fatty liver, alcoholic, microbiota, hepatitis b, chronic, infections, hepatitis | N/A | Enrolling by invitation | 2023 |
| Comparing P1101 to Entecavir in Patients With HBeAg( ) Hepatitis B Under Long term Nucleos(t)Ide Analogue Therapy NCT05494528 — injections, hepatitis b virus, herpesviridae infections, nucleosides, hepatitis, chronic, herpesviridae, herpesvirus 1, cercopithecine, viruses, hepatitis a, hepatitis b e antigens, therapeutics, hepatitis b, injections, subcutaneous, hepatitis b, chronic, infections, hepatitis, virus diseases | N/A | Recruiting | 2021 |
| Disease Loads and Status of Treatment NCT05264272 — diabetes mellitus, hepatitis b surface antigens, tea, creatinine, hepatitis d, coffee, hepatitis, chronic, hepatitis a, genotype, hepatitis b e antigens, therapeutics, blood platelets, history, hepatitis b, dna, smoking, hepatitis b, chronic, infections, hepatitis, child, rna | N/A | Recruiting | 2022 |
| Research Study on Whether Semaglutide Works in People With Non alcoholic Steatohepatitis (NASH) NCT04822181 — liver diseases, skin, non-alcoholic fatty liver disease, liver, alcoholics, research, fatty liver, fatty liver, alcoholic, semaglutide | Phase 3 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map